Atlas Trials

[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors

Clinical trial NCT05619016 · UNKNOWN

Trial details

NCT number
NCT05619016
Sponsor
Karolinska University Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal NeoplasmsGastric Neoplasms MalignantBreast CancerHER2-positive Gastric Cancer
Start date
2022-11-23
Primary completion
2025-12-31
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.